ArticleBMC medical imaging2025
Predictive value of contrast-enhanced ultrasound in assessing the risk of recurrent in ipsilateral anterior circulation ischemic stroke.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeTo evaluate the value of conventional ultrasound and contrast-enhanced ultrasound (CEUS) in predicting the risk of recurrence in patients with ipsilateral anterior circulation ischemic stroke (ACIS).
methodsThe clinical, laboratory, and ultrasound data of 295 patients who were hospitalized for their initial ACIS between January 2016 and May 2023 were collected. Based on 6–24 months follow-up results, patients were categorized into two groups: the recurrence group and the non-recurrence group. Differences in clinical characteristics, laboratory tests, and ultrasound findings between the two groups were analyzed.
resultsStatistically significant differences were observed between the recurrence and non-recurrence groups in terms of age, carotid plaque side, and CEUS grade (P < 0.05). Multivariate analysis identified CEUS grade as an independent risk factor for ACIS recurrence(P = 0.032). A CEUS grade ≥ 2 demonstrated high predictive accuracy for recurrence, with a sensitivity of 91.04%, specificity of 85.09%, and overall accuracy of 86.44%.
conclusionCEUS grade could independently predict the recurrence risk of ipsilateral ACIS, providing valuable insights for the clinical management and prevention of recurrent ipsilateral ACIS in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.